AurkA inhibitors enhance the effects of B-RAF and MEK inhibitors in melanoma treatment
Emilia Caputo(Institute of Genetics and Biophysics), Paolo A. Ascierto(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale")
Cited by 50
Related Papers
The role of BRAF V600 mutation in melanoma
|Journal of Translational Medicine|2012|798